Tag: CLTX

  • Stock Touching New Lows at NASDAQ: UTi Worldwide (NASDAQ:UTIW), Ventrus (NASDAQ:VTUS), Colonial (NASDAQ:COBK), Celsus Therapeutics (ADR) (NASDAQ:CLTX)

    Logistics Company UTi Worldwide Inc. (NASDAQ:UTIW) said it had breached some debt covenants and would report a loss for the fourth quarter due to a weak air freight market, sending its shares down as much as 28 percent in early trading. UTi Worldwide Inc. (NASDAQ:UTIW) stock opened at $10.73 in last session, and closed at $9.84, while the day range of UTi Worldwide Inc. (NASDAQ:UTIW) stock is $9.76 – $10.83. The stock showed a positive weekly performance of -36.10%.

    Recently Ventrus Biosciences Inc. (NASDAQ:VTUS), $34 million micro-mini capped bio tech firm, announced updates from ongoing clinical trial of its drug VEN 307. The study was conducted to study the safety and efficacy profile of the drug. It is a Diltiazem Hydrochloride drug meant for the treatment of patients suffering from pain due to skin break in the elementary tract. Ventrus Biosciences Inc. (NASDAQ:VTUS) stock opened at $1.40 in last session, and closed at $1.36 by losing -3.55%. The 52 week range of $1.36 – $4.69. Company’s market capitalization is $27.06M.

    Colonial Financial Services, Inc. (NASDAQ:COBK) is a savings and loan holding company for Colonial Bank, FSB. Colonial Bank, FSB is a federally chartered savings bank. The Company’s principal business activity is the one- to four-family residential and commercial real estate loans. Colonial Financial Services, Inc. (NASDAQ:COBK) stock increased 2.20% and finished the last session at $12.10. The EPS of the stock remained -0.91. Company’s market capitalization is $45.01M.

    Celsus Therapeutics PLC (ADR) (NASDAQ:CLTX) is a biopharmaceutical company. The Company is focused on the discovery and development of non-steroidal, synthetic anti-inflammatory drugs. The Company has two product candidates: MRX-4 and MRX-6. MRX-4 is a nasal spray for treating allergic rhinitis (or hay fever). Celsus Therapeutics PLC (ADR) (NASDAQ:CLTX) stock opened the session at $6.40, and closed the session at $6.45. The 52 week range of the Celsus Therapeutics PLC (ADR) (NASDAQ:CLTX) stock remained $5.76 – $25.00 and the day range was $5.76 – $6.50.